More stories
Business Insurance
In the News
Concerns over pain-management alternatives prompt state audit
December 11, 2023
Nikki Wilson was among top industry experts interviewed by Business Insurance regarding a recent initiative by the Texas Division of Workers’ Compensation to ensure providers follow state formulary compliance in using gabapentinoids as an opioid alternative for pain management.
Enlyte
Podcast
Exploring Use of GenAI in P&C
December 6, 2023
Mainstream use of generative AI has prompted claims leaders to explore how the technology can be used to improve claims management. And while GenAI certainly offers tremendous opportunities for the P&C industry, tech leaders must be diligent in ensuring the intricate knowledge and experience in claims management is integrated into these programs.
Risk & Insurance
In the News
In Conversation: Enlyte’s Legal and Regulatory Experts on Top Trends to Watch in 2024
December 4, 2023
From shifts in drug costs to state-based workers’ comp system restructuring efforts, these are the trends workers’ comp professionals need to make sure they’re paying attention to.
Enlyte
Article
Ask The Pharmacist: Steroid Medications in Workers’ Compensation
December 1, 2023
In workers’ comp, steroid medications have often played a role in the management of pain related conditions and joint injuries, either alone or incorporated in “trigger point” injections with an anesthetic medication like lidocaine. They are also used to reduce inflammation in the management of certain lung injuries.
Enlyte
Case Study
Combat Rising Medical Costs on First Party Auto Claims
November 21, 2023
Enlyte’s auto bill review solution reduced the medical bill by an average of 80%— so our customer pays 20 cents for every dollar charged.
Enlyte
Article
Not All PBMs are Created Equally: Examination the Differences Between Traditional Health Care and Workers’ Compensation
November 15, 2023
Explore the key differences between healthcare and workers' compensation PBMs, and the unique regulatory challenges they face in this detailed analysis.